Deubiquitinase USP29 Governs MYBBP1A in the Brains of Parkinson’s Disease Patients
The inactivation of parkin by mutation or post-translational modification contributes to dopaminergic neuronal death in Parkinson’s disease (PD). The substrates of parkin, FBP1 and AIMP2, are accumulated in the postmortem brains of PD patients, and it was recently suggested that these park...
Main Authors: | Areum Jo, Yunjong Lee, Chi-Hu Park, Joo-Ho Shin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/1/52 |
Similar Items
-
Repression of rRNA transcription by PARIS contributes to Parkinson's disease
by: Hojin Kang, et al.
Published: (2015-01-01) -
Loss of MYBBP1A Induces Cancer Stem Cell Activity in Renal Cancer
by: Blanca Felipe-Abrio, et al.
Published: (2019-02-01) -
MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis
by: Akaogi Kensuke, et al.
Published: (2013-02-01) -
c‐MYB‐ and PGC1a‐dependent metabolic switch induced by MYBBP1A loss in renal cancer
by: Blanca Felipe‐Abrio, et al.
Published: (2019-07-01) -
The Tumor Suppressor Roles of MYBBP1A, a Major Contributor to Metabolism Plasticity and Stemness
by: Blanca Felipe-Abrio, et al.
Published: (2020-01-01)